Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Pharmacy (Basel, Switzerland)|May 27, 2026
Effect of Pharmacist-Led Educational Intervention on Switching to Generic Medicine Among Patients Using Brand-Name Medicines in JapanTomohiko Tairabune, Terutaka Goto, Kentaro Yamazaki, et al.Pharmacotherapy|January 28, 2026
Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin-Induced NephrotoxicityYoshihiko Matsuki, Ken-Ichi Sako, Yutaro Kozima, et al.Therapeutic Drug Monitoring|July 12, 2021
Population Pharmacokinetics of Teicoplanin and Its Dosing Recommendations for Neutropenic Patients With Augmented Renal Clearance for Hematological MalignanciesKen-Ichi Sako, Yuta Nakamaru, Kazuro Ikawa, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 4, 2014
[Influence of temperature and humidity on physico-pharmaceutical characteristics of Rasilez(®) tablets]Yuki Nakamura, Takanori Nakajima, Masanori Iwata, et al.Experimental Gerontology|August 26, 2020
Oral administration of porcine liver decomposition product for 4 weeks enhances visual memory and delayed recall in healthy adults over 40 years of age: A randomized, double-blind, placebo-controlled studyYoshikazu Matsuda, Hisao Haniu, Tamotsu Tsukahara, et al.Journal of Pharmaceutical Health Care and Sciences|January 9, 2023
Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritisTomoko Mizaki, Hironobu Nobata, Shogo Banno, et al.Biomedical Reports|December 9, 2024
Effect of infusion time on risk of Bacillus cereus bloodstream infections in patients administered with BFLUID amino acid infusions via peripheral venous cathetersAtsushi Takano, Yuta Nakamaru, Ken-Ichi Sako, et al.Biomedical Reports|August 11, 2022
Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumabTakeshi Chiba, Haruki Ujiie, Yukiko Yaegashi, et al.Cancer Chemotherapy and Pharmacology|November 20, 2025
Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration dataSakiko Kimura, Ken-Ichi Sako, Nao Kikkawa, et al.ACS Biomaterials Science & Engineering|December 15, 2020
Multiwall Carbon Nanotube Composites as Artificial Joint MaterialsAtsushi Sobajima, Takumi Okihara, Shigeaki Moriyama, et al.Pageof 3